ArticleNursing in critical care2026
Long-Term Recovery After Severe Sepsis: A Case Study of Rhabdomyolysis and Suspected Remifentanil Withdrawal During ICU Recovery.
Article in Nursing in critical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe sepsis requiring prolonged intensive care and advanced life support may be followed by complex recovery-phase complications that are difficult to recognise. This case study describes the critical care nursing management and long-term recovery of a 60-year-old woman with severe sepsis who developed rhabdomyolysis during post-ECMO recovery and suspected remifentanil withdrawal during ventilator weaning. Nursing care focused on continuous assessment, early recognition of complications, renal protection, symptom monitoring during opioid tapering, nutrition support, family communication and staged rehabilitation. After 62 days of intensive care, the patient regained independent ambulation and was successfully weaned from remifentanil. At follow-up in February 2026, she was living independently without readmission, with stable renal function, PaO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.